Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Mind your manners and speak of things you know. I have been a critic of mgmt and their lack of communication for the 8yrs I have held this stock.
Trying to get through .99 with 30 minutes to go. Like I said earlier. any close above .98 would be the highest close in 5 months. Over $1.03 would hopefully set 200DMA as support.
I expect a full presentation and explanation of the Journal article and TLD that will precede ASCO.
I think we make another run this afternoon. To me, the number we want is .99 or better. Last time we closed above .98 was November 18th 2021, five months ago!!
NWBO needs back to back to back 20+ million share days after good news to move this stock enough to roast the shorts.
Looks like any push through .97 will have to come in the afternoon.
Yeah, looks like someone dumped 200,000 shares in one pop. FeMike?
Need to get through this block at .97 Marzan, minions please.....
annie post
@apwriter
Replying to
@biggercapital
Big holders are fighting back...locked their shares. Zero available to short. Squeeze. Over $2.50 by then. $nwbo
11:50 AM · Apr 17, 2022·Twitter for iPhone
The battle is on. Lappin, Bigger and others pointing to TLD prior to or at ASCO (I believe before). 6 month daily chart shows the 200DMA and last resistance of $1.03 with blue skies to $1.25. DMI looks good. If we make a run this week and hold above $1.03, could be perfect set up for blast off with news.
Pretty sure that ship has sailed. Money spent. If this turns out to be another "we were hoping to be ready by then" May-June season of conferences, only to cancel or regurgitate 4 yr old data points (while everyone knows TLD is in hand), PPS will drop like a rock.
And yet we keep sitting, waiting and wagging our tails.
It certainly seems that the upcoming conference circuit and listed participants could finally mean we see TLD/Journal. I only give it a 60/40 chance (in favor) however. Why?
1. They have pulled out of and changed presentations last minute in the past.
2. They have scheduled placeholder presentations likely hoping they were ready, only to cancel. This could happen again.
3. They have attended some with old data and discussions around the trial, not about the trial. This could happen again.
Over 18 months past data lock and with the scheduled events being posted, one would like to believe this is finally our time. ASM, multiple events, all the big names are involved to present. I would like to see confirmation prior to end of April with a PR about ASM date and agenda. And, if this is the beginning of the victory tour, I would expect TLD/Journal before the end of April, but I am skeptical at this point.
I believe you have been posting intra-day short positions. That is what MM's do. Fill trades, even if they are short, then backfill to even out at the end of the day. FINRA short interest totals are more accurate as an indicator of % short, but even they are two weeks old when reported.
Maybe, but they trade amongst themselves, for less than a penny. I have a buy for 10k at .91 and they sit on the bid at .9101. It's laughable this manipulation.
Yep. All the hype over some new conference presentations only to find they are a bunch of nothing burgers.
This is not the outstanding number of shares short. This volume or percentage can show MM manipulation, However. FINRA reports outstanding short shares bi-weekly.
LP herself ended the run up! At the ASM she said there were rumors about ASCO and she clearly said they were not presenting anything there.
$1 will be a little more difficult, IMO. We have attempted it twice since December and got smacked back down.
It's trying.
Trying to hold this under .90
If it get's through, clear sailing to $1.00
I believe there is a buyer out there. I wouldn't be surprised to see another run into close.
Indeed. Bravo!
We've got a runner. Did Gus Leak?
LP has never said manufacturing is a prerequisite for TLD. And, LP, et al., likely saw the unblinded data a long time ago. Yes, they write a TLD PR but they know the data beforehand. There is no way you could stay out of jail for spending millions and committing millions more on production if you didn't believe the data had a very good chance of approval.
Bigger bid/ask than usual. I sense activity today. Somehow this needs to get above .78 and we should see Sojo's Pop.
All I know is that it will be 18 months tomorrow since data lock. Other than hoping we are close, there is still no way to know where we are with TLD/Journal. Awful communication from this company.
What do you mean? Didn't you read all the interpretation from those on this board who know more than you? It was a stellar presentation, with no confusion, and clearly confirming the efficacy of our phase 3?
What happened to the POP that was coming? And, after hours leak?
Another loan, if from the same group will either cost more or not be offered. There is a limited amount of non-public info that can be provided, IMO. Even with an NDA. So, it is likely the loan group was initially told that TLD was going to happen in time to release TLD and get manufacturing up and running so as to mitigate risk and begin repayment (last November). Another loan with a repayment date was taken with another 9? month term for repayment to begin. If they are looking to the same lender, this would be the third time they move the goal posts. I don't see that happening until TLD.
How long can they have Dr's out there in public, beating around the bushes on this trial and the results before they have to tell us what is going on? The ridiculous speculation this causes is worse than the purported short attacks that may or may not happen if they gave an update. "LL said this, it means this" "No it doesn't, it means this" "they are referencing this trial on this number of patients"....ALL pure speculation, and, driven by this mgmt team and this stupid quiet period.
Easy fix....get your leaked news out now instead of after the bell.
Is that why we are red today?
$18 bid would be fantastic. However, based on LP's history, she would likely still try to go it alone.
Deep within BP, with all of their eyes and ears looking at what's out there and potential opportunities and competition, why isn't there an offer for NWBO yet?
BP understands the value of small biotechs better than anyone else. They know what these companies are trying, and they know what is working based on what they have tried. Just the patent portfolio and data sets would be worth billons. So, why no interest in NWBO?
There are no shorts. This is an easily manipulated OTC stock with no volume and a lot of shares. Oh, and never any PR's to interrupt the manipulation.
I disagree. They are choosing not to, this is a slef-imposed "quiet period." I was also fine with a quiet period when they decided to pivot (from multiple statements of topline by Sept 2019) after data lock. There is no way they could have thought we would still be where we are 18 months later. So, an update is possible and warranted and they still choose not to provide one. THAT is why we are at .68.
I didn't say anything about Sawston or UK Specials. And, I didn't say I disagreed with TLD/Journal or 3rd party recommendations. All I have been saying is that after 18 months we should have an update from the company on where we are. It doesn't have to give timelines, tell us what is happening with TLD and Journal beyond referring us back to a vague PR from 18 Months ago.
Who knows. I thought .73 was low last week and look what that got me. The funny part is all of the defenders of the silence because the "shorts could FUD any update." Looks like they are doing just fine at .69 without news, how much could they actually hurt a .69 stock even if they think the data will be bad (if it ever comes out). It's not a good risk/reward with a binary event looming. That's what an update would do, chase the shorts away.
Yes, a more complicated data set. However, It's a small data set, 331 patients and death events limit the total tracking time for many. So, even splitting those comparison categories...Pseudo, crossover, IDH, etc....its a handful of tables for endpoint comparison. All the Covid delay issues, mostly for tissue/slide gathering, should have been done a year ago (or by data lock), and the comparison tables for endpoints as well.
That's why I get frustrated. There is nothing from the company that says days/weeks vs. months/years....Literally, none.
Yes, unblinded data statistically HAS to be better unless you believe placebos outlived historical norms. GBM has never shown that and the odds of choosing a group that outlives the 14-16 months is almost impossible.